STOCK TITAN
  1. Home
  2. Sec-filings
  3. ONCO
  4. [SCHEDULE 13D/A] Onconetix, Inc. SEC Filing

[SCHEDULE 13D/A] Onconetix, Inc. SEC Filing

Filing Impact
(Low)
Filing Sentiment
(Neutral)
Form Type
SCHEDULE 13D/A

Filing content is currently unavailable.

Source: View Original Filing on SEC EDGAR

Stock ONCO logo
Onconetix

NASDAQ:ONCO

ONCO Rankings

#6368 Ranked by Market Cap
N/A Ranked by Dividends

ONCO Latest News

Jul 16, 2025
Onconetix and Ocuvex Therapeutics announce execution of definitive merger agreement
Jun 16, 2025
Onconetix, Inc. Announces Positive Decision by Nasdaq Hearings Panel
Jun 11, 2025
Onconetix, Inc. Announces 1-for-85 Reverse Stock Split and Results of the Special Meeting of Stockholders
May 22, 2025
Onconetix, Inc. Announces Receipt of Additional Notice from Nasdaq
Apr 30, 2025
Onconetix, Inc. Announces Receipt of Additional Notice from Nasdaq

ONCO Latest SEC Filings

Sep 4, 2025
[8-K] Onconetix, Inc. Reports Material Event
Aug 19, 2025
[Form 4] Onconetix, Inc. Insider Trading Activity
Aug 19, 2025
[Form 4] Onconetix, Inc. Insider Trading Activity
Aug 19, 2025
[Form 4] Onconetix, Inc. Insider Trading Activity
Aug 19, 2025
[Form 4] Onconetix, Inc. Insider Trading Activity

ONCO Stock Data

4.44M
1.24M
19.74%
0.6%
14.44%
Biotechnology
Pharmaceutical Preparations
Link
United States
CINCINNATI